Dean Erhardt
2026 Pharma Outlook & Why Conventional Strategies Will Fail
Outlook Overview We continue to be in an "Age of Volatility" where adaptability is the ...
Patients are Becoming the CEOs of their Healthcare Journeys
Overview: Supporting patients in becoming the CEOs of their own health journeys.
Charting the Course for 2025 | A Letter from the CEO
As we prepare to step into 2025, I find myself reflecting on the twists and turns of ...
Specialty Pharma and Patient Engagement: The Key to Enrollment and Adherence Success
Overview: Pharma & Patient Engagement in 2025 Several instances I’ve been asked: what ...
Navigating the 2025/26 Pharma Product Launch Landscape
The pharmaceutical landscape is constantly evolving, and as we look ahead to 2025 and ...
Immediate Impacts of the Inflation Reduction Act of 2022
Perhaps the biggest shift Pharma has seen in the last 2 years is the
The New Way To Optimize Pharma Market Access
Launching a specialty product in 2025? Learn More The pharmaceutical industry is ...
The Reauthorization Blizzard: Simplify Prior Authorizations in 2024
Drowning in prior authorizations already? You're not the only one.
Issue: Losing Money in Healthcare Delivery
The healthcare industry faces several challenges still because of the COVID-19 pandemic, ...